Chlorpheniramine poisoning as a potential cause of rhabdomyolysis.
Case report
Chlorpheniramine
Poisoning
Rhabdomyolysis
Journal
The American journal of emergency medicine
ISSN: 1532-8171
Titre abrégé: Am J Emerg Med
Pays: United States
ID NLM: 8309942
Informations de publication
Date de publication:
07 2022
07 2022
Historique:
received:
13
02
2022
revised:
21
03
2022
accepted:
07
04
2022
pubmed:
24
4
2022
medline:
7
6
2022
entrez:
23
4
2022
Statut:
ppublish
Résumé
Chlorpheniramine is an H1 receptor antagonist of the alkylamine class. It is a widely used anti-allergy drug due to its strong antihistamine effect and mild adverse effects. In the case of chlorpheniramine overdose or poisoning, the primary manifestation is central nervous system symptoms. To date, no case of rhabdomyolysis induced by acute poisoning with chlorpheniramine has ever been reported. This study reports a case of acute chlorpheniramine poisoning at an oral dose of 4000 mg, which is the highest reported poisoning dose to date. The diagnosis of rhabdomyolysis (creatine kinase, 195,489 U/L) and acute kidney injury (serum creatinine, 150.1 umol/L) was confirmed based on laboratory results. After haemoperfusion and continuous renal replacement therapy, the patient's renal function fully recovered. This paper aims to analyse the clinical data of this patient and summarize its clinical characteristics. At the same time, the mechanism of chlorpheniramine-induced rhabdomyolysis is also explored in the context of the literature review.
Identifiants
pubmed: 35459564
pii: S0735-6757(22)00242-X
doi: 10.1016/j.ajem.2022.04.010
pii:
doi:
Substances chimiques
Histamine H1 Antagonists
0
Chlorpheniramine
3U6IO1965U
Creatinine
AYI8EX34EU
Creatine Kinase
EC 2.7.3.2
Types de publication
Case Reports
Langues
eng
Sous-ensembles de citation
IM
Pagination
236.e1-236.e3Informations de copyright
Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest All authors have read and approved the submitted manuscript, the manuscript has not been submitted elsewhere nor published elsewhere in whole or in part. Additionally, all authors have approved and contributed to the contents of this paper and have agreed to The American Journal of Emergency Medicine submission policies. The named authors have no conflict of interest, financial or otherwise.